Trial intelligence / Profile preview

Celebrex in Acute Renal Colic

NCT00304317Phase 4Withdrawn

Sponsor
University of Minnesota
Start
Mar 2006
Primary completion
Aug 2008
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of celecoxib oral solution in ureteral calculus, sponsored by University of Minnesota. Primary endpoint: Decrease in narcotic usage at 48 hours. Planned start Mar 2006; status: withdrawn.

02

Drugs

celecoxib oral solution
03

Conditions

ureteral calculus

Beyond the preview

Go deeper on NCT00304317.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00304317.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call